Humacyte, Inc. (HUMA)
1.31
+0.04
(+3.15%)
USD |
NASDAQ |
Dec 11, 16:00
1.315
0.00 (0.00%)
After-Hours: 20:00
Humacyte EPS Diluted (Quarterly): -0.1106 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CorMedix, Inc. | 1.259 |
| Rockwell Medical, Inc. | -0.0487 |
| Nuwellis, Inc. | 0.5608 |
| Salarius Pharmaceuticals, Inc. | -1.814 |
| Biomea Fusion, Inc. | -0.2741 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -17.51M |
| Revenue (Quarterly) | 0.753M |
| Total Expenses (Quarterly) | 18.26M |
| Enterprise Value | 276.26M |
| Gross Profit Margin (Quarterly) | -182.2% |
| Profit Margin (Quarterly) | -2.33K% |
| Earnings Yield | -18.23% |
| Normalized Earnings Yield | -49.02 |